Search Results

VV330 Continuous ECG Platform is a wireless recording system intended for use by healthcare professionals for record and display of physiological data within healthcare settings or at home. This includes electrocardiogram (ECG), accelerometer data, R-R Interval and heart rate. Data is transmitted wirelessly to a separate location (such as a mobile phone) for storage and display. The VV330 Continuous ECG Platform can be configured by Authorized Persons to modify or merge or ignore any of the operational alerts, but not to set new alerts related to physiological data.

The device is not intended to be used on critical care patients and is intended to supplement vital signs recording for later viewing by healthcare professionals, not to replace current standards of care. The device is an ambulatory, continuous recording system intended for use on general care patients and on patients who are 18 years of age or older.

The VV330 Continuous ECG Platform is a single-channel, rechargeable, re-usable, ambulatory medical-grade continuous ECG recorder, intended for use by healthcare professionals for record and display of physiological data within healthcare settings or at home.

The device is not intended to be used on critical care patients and is intended to supplement vital signs recording for later viewing by healthcare professionals, not to replace current standards of care. The device is an ambulatory, continuous recording systems intended for use on general care patients and on patients who are 18 years of age or older.

The VV330 Continuous ECG Platform is an ECG acquisition, storage, and transmission devices that utilizes disposable adhesive to maintain contact with the patient's skin and a hydrogel to promote electrical connectivity. The Platform has a re-usable sensor/recorder module allowing collection, storage and transfer of physiological data such as electrocardiogram (ECG), Accelerometer data, R-R Interval (RRI) and Heart Rate (HR). The Platform has a mobile data-display application built from a proprietary Software Library. And it also allows Authorized Persons to build their own applications using the same Software Library.

User's physiological are not transferred to healthcare professionals directly in any way; healthcare professionals can only view the data on the intended device (such as a mobile phone). User may view the physiological data in real time from the smart phone (or similar devices) while it records the data.

The Subject device provides operational alarms such as lead on/off status detection, battery monitoring, Over the Air (OTA) updates, real time clock, and power management. The operational alarms are intended to notify users of any interruption in data and of the overall operation status of the Recorder. The Subject device, being just a Transmitters and Receivers of Physiological Signal, does not provide any alarms based on physiological data setting.

The provided text describes the VV330 Continuous ECG Platform, but it does not contain the specific acceptance criteria or the details of a comparative study proving the device meets these criteria.

The document is a 510(k) summary, which focuses on demonstrating substantial equivalence to predicate devices rather than providing detailed performance study results against specific acceptance criteria. While it lists recognized standards that the device conforms to, it does not explicitly state performance metrics or the methodology of studies used to prove these metrics.

Therefore, I cannot fulfill your request for:

1. A table of acceptance criteria and reported device performance.
2. Sample size used for the test set and data provenance.
3. Number of experts and their qualifications for ground truth.
4. Adjudication method for the test set.
5. MRMC study details or effect size of AI assistance.
6. Stand-alone algorithm performance.
7. Type of ground truth used.
8. Sample size for the training set.
9. How ground truth for the training set was established.

The document only provides the following relevant information:

• Device Name: VV330 Continuous ECG Platform, VivaLNK Adhesive Patch.
• Intended Use/Indications for Use: Wireless recording system for record and display of physiological data (ECG, accelerometer, R-R Interval, heart rate) for healthcare professionals, intended for supplementary use on general care patients 18 years or older, at home or healthcare settings. Not for critical care, not to replace current standards of care.
• Performance Claim (Heart Rate Accuracy): 95% accuracy against true heart rate value under ambulatory conditions (this is a claim made in the comparison table, but no study details are provided to support it in terms of methodology or sample size).
• Standards Conformed To (listed in "Performance Data" section):
  • ISO14971:2007/(R)2010 (Risk Management)
  • ANSI AAMI ISO 10993-5:2009/(R)2014 (Cytotoxicity)
  • ISO 10993-10 Third Edition 2010-08-01 (Irritation and Skin Sensitization)
  • AAMI/ANSI EC-12:2000/(R)2012 (Disposable ECG electrodes)
  • ANSI AAMI ES60601-1:2005 (Third Edition) +CORR. 1:2006 + CORR. 2:2007+A1:2012 (General requirements for basic safety and essential performance)
  • IEC 60601-1-2 Edition 4.0 2014-02 (Electromagnetic disturbances)
  • IEC 60601-1-11:2015 Part 1-11 (Home healthcare environment requirements)
  • ANSI AAMI IEC 60601-2-47:2012 (Second Edition) (Ambulatory electrocardiographic systems)
  • ANSI IEEE C63.27-2017 (Wireless Coexistence)
  • IEC 62304: 2015 (Application of Usability Engineering to Medical Devices)

The "Performance Data" section merely states that "VivaLNK, Inc. ("VivaLNK") completed the appropriate design verification activities... through software, hardware, mechanical, biocompatibility, packaging tests, and electromagnetic compatibility testing." It confirms compliance with recognized standards but does not provide any specific study protocols, results, sample sizes, or ground truth establishment methods for demonstrating the device meets a set of performance acceptance criteria.

In the context of the prompt, the document lacks the detailed information typically found in a clinical study report or a more comprehensive validation test report.

Ask a specific question about this device

The wireless Fever Scout™ Continuous Monitoring thermometer is a non-invasive and re-usable electronic device for home use and a non-invasive and single patient use in the hospital. This product is intended for non-urgent ambulatory continuous armpit body temperature monitoring from ages 29 days and older.

The VivaLnk Fever Scout VV-200 is an ambulatory continuous body temperature monitor designed for armpit location, and uses Bluetooth Low Energy (BLE) for wireless communication with the Smartphone app for temperature display, trending and alert. The product is composed of The Fever Scout VV-200 patch, The Smartphone app (supporting Apple iOS and Android devices), AAA charging system with BLE relay function, Eight disposable adhesives.

The provided text describes the regulatory filing for a medical device, the Fever Scout Continuous Monitoring Thermometer (K181013), and its substantial equivalence to previously marketed predicate devices. The study detailed focuses on expanding the indications for use, particularly to include single-patient use in hospitals, rather than on proving new performance characteristics of the device itself.

Based on the information provided, here's a breakdown of the acceptance criteria and the study that proves the device meets them:

I. Acceptance Criteria and Reported Device Performance

The acceptance criteria for the Fever Scout™ Continuous Monitoring Thermometer are primarily based on its equivalence to existing predicate devices, particularly regarding its technical characteristics and compliance with recognized standards. Since the K181013 submission is for expanded indications for use (adding single-patient use in hospitals) for an identical product (VV-200) that was previously cleared (K162137), the performance acceptance criteria are implicitly those that the original predicate device met, and this submission seeks to demonstrate that the expanded use does not introduce new risks or alter its fundamental performance.

The table below summarizes the technical characteristics that serve as de facto "acceptance criteria" through comparison with predicates, along with the reported performance of the proposed device. The "Performance" section within the document refers to compliance with standards, indicating that meeting these standards serves as the primary proof of performance.

Table 1: Acceptance Criteria (Based on Predicate Equivalence) and Reported Device Performance

II. Study Details for Proving Acceptance Criteria

The document does not detail a new clinical study with a test set, expert readers, or ground truth establishment in the traditional sense of an AI model performance study. Instead, the proof of meeting acceptance criteria for this K181013 submission relies on:

1. Demonstrating Substantial Equivalence: The primary method is to show that the proposed device (with expanded indications) is identical to a previously cleared predicate (K162137) for home use and comparable to a secondary predicate (K160306) for institutional use.
2. Compliance with Recognized Consensus Standards: The document explicitly states that the device "Conformed to" or "Complied with" various international and ASTM standards (ISO 10993 series for biocompatibility, IEC 60601-1 for electrical safety and electromagnetic compatibility, and ASTM E1112 for performance of clinical thermometers). Adherence to these standards is considered sufficient evidence of safety and basic performance.
3. Risk Management for Expanded Use: For the expanded "single patient use in the hospital," the submission addresses potential new risks (specifically cross-contamination) through a "Fever Scout Risk Management Report" and proposed procedural controls (labeling and IFU precautions). This is a mitigation strategy rather than a performance study.

Given this context, many of the requested details for a typical AI model study are not applicable or explicitly stated in this regulatory submission document.

• Sample size used for the test set and data provenance: Not explicitly detailed as a separate clinical test set for performance validation in this submission. The validation is through comparison to predicates and compliance with standards. If a test set was used for the original predicate's clearance (K162137) to meet ASTM E1112, those details are not provided here.
• Number of experts used to establish the ground truth for the test set and the qualifications of those experts: Not applicable. Ground truth for clinical thermometer performance is typically established through a known temperature reference (e.g., black body calibrators for laboratory accuracy tests, or controlled clinical studies comparing to a gold standard thermometer), as part of compliance with standards like ASTM E1112. The document doesn't describe the expert consensus process for a test dataset.
• Adjudication method (e.g., 2+1, 3+1, none) for the test set: Not applicable.
• If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance: Not applicable. This device is a thermometer, not an AI diagnostic tool primarily assisting human readers.
• If a standalone (i.e. algorithm only without human-in-the loop performance) was done: The device itself is "standalone" in continuously measuring temperature. Its performance is measured against established accuracy standards (ASTM E1112), not comparative human interpretation.
• The type of ground truth used (expert consensus, pathology, outcomes data, etc.): For thermometer performance, the ground truth is typically a highly accurate reference thermometer or a controlled temperature environment, as per standards like ASTM E1112. The document doesn't detail how ground truth was established for a specific "test set" in this submission.
• The sample size for the training set: Not applicable. This is not an AI model that undergoes a "training" phase with a dataset.
• How the ground truth for the training set was established: Not applicable.

In summary, the device's acceptance is based on its demonstrated substantial equivalence to predicate devices and its compliance with relevant performance and safety consensus standards, rather than a new, extensive clinical study detailing specific test sets, expert ground truth, or MRMC analyses. The expansion of indications for hospital use is addressed through a risk management approach for cross-contamination.

Ask a specific question about this device

The wireless Fever Scout™ Continuous Monitoring thermometer is a non-invasive and re-usable electronic device for home use. This product is intended for non-urgent ambulatory continuous armpit body temperature monitoring from ages 29 days and older.

Fever Scout Continuous Monitoring thermometer is an ambulatory continuous body temperature monitor designed for armpit location, and uses Bluetooth Low Energy (BLE) for wireless communication with the Smartphone app for temperature display, trending and alert. This product is composed of The Fever Scout VV-200 patch, The Smartphone app (supporting iOS), AAA charging system with BLE relay function, and Eight adhesives. The patch hardware primarily includes the following function modules: 1) temperature sensor, 2) control module, 3) Bluetooth Low Energy (BLE) communication module and 4) battery. All are integrated onto a flexible electronic printed circuit board. A MS Lithium rechargeable battery is attached to the board to supply 3.0V DC internal power. The app includes 1) User account, profile and alert temperature setup and 2) GUI for temperature display, trending and alerts. The charging system provides a cordless charging method to the patch, a storage to the replaceable double-sided adhesives, as well as an alternative BLE communication channel from the patch to the charger and then to the iPhone, in order to extend communication range. This product contains Type B applied part (per IEC 60601-1: 2012). All components, the patch, charger and adhesives are all user accessible parts. However, the user is only expected to change the charger AAA batteries, but not to open or modify any other parts of the product.

Here's a breakdown of the acceptance criteria and the study information for the "Fever Scout™ Continuous Monitoring thermometer," based on the provided text:

1. Table of Acceptance Criteria and Reported Device Performance:

Note on Acceptance Criteria and Performance: The document mainly uses the phrase "Equivalent" or "Identical" when comparing to predicates, and then states that the device "meets" or "conforms" to specific standards. The specific numerical acceptance criteria for the predicates (where available) are inferred here to represent the bar the Fever Scout had to meet for substantial equivalence.

2. Sample Size Used for the Test Set and Data Provenance:

• The document mentions "product verification, software verification, user/usability validation, biocompatibility test, mechanical hazards test, EMC test and IEC 60601-1 safety compliance test" as the performance data.
• Specific sample sizes for a clinical test set are not explicitly mentioned in this 510(k) summary. It refers to compliance with standards like ASTM E1112, which typically involve specific test methodologies and potentially human subjects for accuracy testing, but the number of subjects or samples is not provided here.
• Data Provenance: Not explicitly stated as retrospective or prospective for a specific clinical study related to accuracy with human subjects. The tests mentioned are performance and safety engineering tests. No country of origin for specific human subject data is provided.

3. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications of Those Experts:

• This information is not provided in the document. For a thermometer, "ground truth" for accuracy is typically established by comparing the device's readings to a highly accurate reference thermometer in a controlled environment or in vivo with a controlled reference method. Experts would likely be involved in designing and executing such tests, but their number and qualifications are not detailed.

4. Adjudication Method for the Test Set:

• This information is not provided as there is no mention of a traditional expert-adjudicated test set in the context of diagnostic performance (e.g., medical image interpretation). For a thermometer, accuracy is typically determined through direct comparison with a traceable reference, not through adjudication.

5. Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study:

• No, an MRMC comparative effectiveness study was not done. This type of study is typically performed for diagnostic imaging devices where human readers interpret medical cases with and without AI assistance. This device is a thermometer, and the evaluation focuses on its direct measurement accuracy and safety, rather than its impact on human reader performance.

6. Standalone (i.e., algorithm only without human-in-the-loop performance) Study:

• Yes, a standalone performance was done for the thermometer's core function. The accuracy, measurement range, and operating conditions are assessed directly for the device itself, conforming to standards like ASTM E1112. The "algorithm" here is the temperature sensing and processing, and its output (temperature reading) is evaluated against reference standards. The device is intended for continuous monitoring and displays information via a smartphone app. Its performance is inherent to the device's measurement capabilities.

7. Type of Ground Truth Used:

• The ground truth for thermometer performance (e.g., accuracy) is typically established by comparing the device's measurements to that of a traceable reference thermometer or a recognized standard temperature source in a controlled laboratory setting, as defined by standards like ASTM E1112. For biocompatibility and electrical safety, the ground truth is adherence to the specified international standards (e.g., ISO 10993, IEC 60601-1).

8. Sample Size for the Training Set:

• This information is not applicable and not provided. The "Fever Scout™ Continuous Monitoring thermometer" is a sensor-based medical device, not an AI/ML diagnostic algorithm that requires a separate "training set" of data in the conventional sense. Its temperature sensing and processing are based on established physics and sensor technology, verified through engineering tests and adherence to standards.

9. How the Ground Truth for the Training Set Was Established:

• This information is not applicable and not provided for the same reason as point 8.

Ask a specific question about this device